GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » NervGen Pharma Corp (TSXV:NGEN) » Definitions » 5-Year Yield-on-Cost %

NervGen Pharma (TSXV:NGEN) 5-Year Yield-on-Cost % : 0.00 (As of May. 02, 2025)


View and export this data going back to 2019. Start your Free Trial

What is NervGen Pharma 5-Year Yield-on-Cost %?

NervGen Pharma's yield on cost for the quarter that ended in Dec. 2024 was 0.00.


The historical rank and industry rank for NervGen Pharma's 5-Year Yield-on-Cost % or its related term are showing as below:



TSXV:NGEN's 5-Year Yield-on-Cost % is not ranked *
in the Biotechnology industry.
Industry Median: 1.685
* Ranked among companies with meaningful 5-Year Yield-on-Cost % only.

Competitive Comparison of NervGen Pharma's 5-Year Yield-on-Cost %

For the Biotechnology subindustry, NervGen Pharma's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


NervGen Pharma's 5-Year Yield-on-Cost % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, NervGen Pharma's 5-Year Yield-on-Cost % distribution charts can be found below:

* The bar in red indicates where NervGen Pharma's 5-Year Yield-on-Cost % falls into.


;
;

NervGen Pharma 5-Year Yield-on-Cost % Calculation

Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.

Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.

Therefore, Yield-on-Cost of NervGen Pharma is calculated as

Yield-on-Cost=Dividend Yield %*(1+Dividend Growth Rate)^5

NervGen Pharma  (TSXV:NGEN) 5-Year Yield-on-Cost % Explanation

Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.


NervGen Pharma 5-Year Yield-on-Cost % Related Terms

Thank you for viewing the detailed overview of NervGen Pharma's 5-Year Yield-on-Cost % provided by GuruFocus.com. Please click on the following links to see related term pages.


NervGen Pharma Business Description

Traded in Other Exchanges
Address
112-970 Burrard Street, Unit 1290, Vancouver, BC, CAN, V6Z 2R4
NervGen Pharma Corp is a clinical-stage biotech company. The company's principal business activity is the discovery, development, and commercialization of pharmaceutical treatments that enable the nervous system to repair itself following damage, whether due to injury or disease. The company's initial target indication is spinal cord injury. The company's pipeline products include NVG-291 and NVG-300.
Executives
John Ruffolo Director
Krista Mckerracher Director
William Joseph Radvak Director
Harold Punnett 10% Security Holder, Director
Robert Pilz Senior Officer

NervGen Pharma Headlines

No Headlines